The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.
- 1 December 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (24) , 8710-8714
- https://doi.org/10.1073/pnas.82.24.8710
Abstract
Monospecific antiserum to an unusually stable Mr 50,000 plasminogen-activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells was employed in conjunction with reverse fibrin autography to determine whether human platelets serum, and plasma contain immunologically related inhibitors. Reverse fibrin autography revealed the presence of a Mr 50,000 inhibitor in the platelet and serum samples but not in normal plasma. However, a Mr 50,000 inhibitor was detected in plasma obtained from individuals with increased PAI activity. In each case, treatment of the sample with the anti-inhibitor serum removed the Mr 50,000 inhibitor. The inhibitor present in each sample neutralized exogenously added tissue-type plasminogen activator in a rapid manner. Inhibition was associated with the formation of a NaDodSO4-resistant enzyme-inhibitor complex of Mr 120,000. Again, treatment of the samples with the anti-inhibitor serum removed both the inhibitory activity and the inhibitor serum removed both the inhibitory activity and the component in these samples that binds to tissue-type plasminogen activor. Thus, the rapidly acting PAI present in human platelets, serum, and patient plasma is immunologically related to the PAI synthesized by cultured bovine aortic endothelial cells. This molecule may be the physiologically relevant inhibitor of plasminogen activator in the vascular system and, as such, may serve an important role in regulating the initiation of vascular fibrinolysis.This publication has 39 references indexed in Scilit:
- An Inhibitor of Urokinase and Tissue Plasminogen Activators in Dunning R3327H Prostate Tumors of Rats Treated with D-Trp6-LH-RHHormone Research, 1985
- Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasmaBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.Journal of Clinical Investigation, 1984
- Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cellsBiochemical and Biophysical Research Communications, 1983
- Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.Journal of Clinical Investigation, 1982
- DEMONSTRATION OF UROKINASE‐RELATED FIBRINOLYTIC ACTIVITY IN HUMAN PLASMABritish Journal of Haematology, 1982
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Purification of a Plasminogen Activator Inhibitor Indistinguishable from α1-Antitrypsin and an Urokinase Inhibitor in Pregnancy PlasmaPathophysiology of Haemostasis and Thrombosis, 1976
- Studies on an Inhibitor of Plasminogen Activators in Human PlateletsBritish Journal of Haematology, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970